Effective and powerful way to look at this CP.
For all of us to keep in mind -
This collaboration is basically:
1. Putting Bavi in front of EVERY major Oncology institution in the US
2. Putting Bavi in the hands of researchers (Preclinical and Clinical) that have access to EVERY product currently in testing, and those that will enter testing while the collaboration is active
3. Putting the streaming results, as they appear, in front of the collective Research, M&A and Business Development organization/division of EVERY Pharmaceutical Company that does business with at least one of the member institutions. That includes ALL companies that matter
This is not done as a 'spray the walls and see what sticks' approach. This is done because something shows intrigue and promise and the ONLY way to spread into effective parallel work and drive concurrent results is to do this. BPs do this because even $150B behemoths do not have the capacity to broaden their span 10 or 100 fold when the need arises.
Well done deal that is likely able to produce early/directional results as early as 3Q to 4Q this year.
Best,
MH
News 
Market Data 
Discover 
AI
